vs
Side-by-side financial comparison of NovaBay Pharmaceuticals, Inc. (NBY) and Worksport Ltd (WKSP). Click either name above to swap in a different company.
NovaBay Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($4.8M vs $4.7M, roughly 1.0× Worksport Ltd). On growth, NovaBay Pharmaceuticals, Inc. posted the faster year-over-year revenue change (126.1% vs 62.0%). NovaBay Pharmaceuticals, Inc. produced more free cash flow last quarter ($-1.7M vs $-6.3M). Over the past eight quarters, Worksport Ltd's revenue compounded faster (204.2% CAGR vs 42.5%).
NovaBay Pharmaceuticals, Inc. is an Emeryville, California based clinical-stage biopharmaceutical company, focused on products for eye care. Major products include Avenova, cleared by FDA for lid and lash cleansing as part of a regimen for Blepharitis. and NeutroPhase, used in treatment of Necrotizing Fasciitis
Worksport LtdWKSPEarnings & Financial Report
Worksport Ltd is a cleantech company specializing in portable solar energy solutions and custom truck bed accessories. Its core offerings include solar-powered tonneau covers for pickup trucks and portable mobile power stations, serving the North American automotive aftermarket and consumer clean energy segments.
NBY vs WKSP — Head-to-Head
Income Statement — Q4 FY2024 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $4.8M | $4.7M |
| Net Profit | $-1.2M | — |
| Gross Margin | 65.2% | 30.1% |
| Operating Margin | -37.2% | -129.6% |
| Net Margin | -25.5% | — |
| Revenue YoY | 126.1% | 62.0% |
| Net Profit YoY | 70.5% | — |
| EPS (diluted) | — | $-0.65 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $4.7M | ||
| Q3 25 | — | $5.0M | ||
| Q2 25 | — | $4.1M | ||
| Q1 25 | — | $2.2M | ||
| Q4 24 | $4.8M | $2.9M | ||
| Q3 24 | $0 | $3.1M | ||
| Q2 24 | $2.4M | $1.9M | ||
| Q1 24 | $2.6M | $512.6K |
| Q4 25 | — | — | ||
| Q3 25 | — | $-4.9M | ||
| Q2 25 | — | $-3.7M | ||
| Q1 25 | — | $-4.5M | ||
| Q4 24 | $-1.2M | — | ||
| Q3 24 | $-1.2M | $-4.1M | ||
| Q2 24 | $-1.6M | $-4.0M | ||
| Q1 24 | $-3.2M | $-3.7M |
| Q4 25 | — | 30.1% | ||
| Q3 25 | — | 31.3% | ||
| Q2 25 | — | 26.4% | ||
| Q1 25 | — | 17.7% | ||
| Q4 24 | 65.2% | 11.1% | ||
| Q3 24 | — | 7.9% | ||
| Q2 24 | 66.3% | 15.4% | ||
| Q1 24 | 68.2% | 7.3% |
| Q4 25 | — | -129.6% | ||
| Q3 25 | — | -95.6% | ||
| Q2 25 | — | -88.1% | ||
| Q1 25 | — | -190.0% | ||
| Q4 24 | -37.2% | -137.0% | ||
| Q3 24 | — | -125.1% | ||
| Q2 24 | -67.4% | -203.5% | ||
| Q1 24 | -87.1% | -709.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | -98.3% | ||
| Q2 25 | — | -91.0% | ||
| Q1 25 | — | -199.1% | ||
| Q4 24 | -25.5% | — | ||
| Q3 24 | — | -132.4% | ||
| Q2 24 | -66.0% | -208.9% | ||
| Q1 24 | -122.2% | -724.6% |
| Q4 25 | — | $-0.65 | ||
| Q3 25 | — | $-0.75 | ||
| Q2 25 | — | $-0.71 | ||
| Q1 25 | — | $-1.05 | ||
| Q4 24 | — | $-1.14 | ||
| Q3 24 | $-1.92 | $-1.40 | ||
| Q2 24 | $-1.37 | $-1.55 | ||
| Q1 24 | $-29.95 | $-1.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $430.0K | $5.9M |
| Total DebtLower is stronger | — | $2.7M |
| Stockholders' EquityBook value | $-129.0K | $22.9M |
| Total Assets | $3.4M | $30.7M |
| Debt / EquityLower = less leverage | — | 0.12× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $5.9M | ||
| Q3 25 | — | $3.8M | ||
| Q2 25 | — | $1.4M | ||
| Q1 25 | — | $5.1M | ||
| Q4 24 | $430.0K | $4.9M | ||
| Q3 24 | $776.0K | $1.9M | ||
| Q2 24 | $751.0K | $3.4M | ||
| Q1 24 | $1.8M | $3.5M |
| Q4 25 | — | $2.7M | ||
| Q3 25 | — | $2.9M | ||
| Q2 25 | — | $2.5M | ||
| Q1 25 | — | $3.1M | ||
| Q4 24 | — | $5.3M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $22.9M | ||
| Q3 25 | — | $19.8M | ||
| Q2 25 | — | $17.3M | ||
| Q1 25 | — | $20.1M | ||
| Q4 24 | $-129.0K | $17.4M | ||
| Q3 24 | $1.1M | $16.4M | ||
| Q2 24 | $-617.0K | $19.1M | ||
| Q1 24 | $160.0K | $18.9M |
| Q4 25 | — | $30.7M | ||
| Q3 25 | — | $27.0M | ||
| Q2 25 | — | $23.6M | ||
| Q1 25 | — | $26.7M | ||
| Q4 24 | $3.4M | $25.7M | ||
| Q3 24 | $3.9M | $24.9M | ||
| Q2 24 | $3.9M | $27.2M | ||
| Q1 24 | $5.4M | $27.3M |
| Q4 25 | — | 0.12× | ||
| Q3 25 | — | 0.15× | ||
| Q2 25 | — | 0.14× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.30× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.7M | $-6.1M |
| Free Cash FlowOCF − Capex | $-1.7M | $-6.3M |
| FCF MarginFCF / Revenue | -35.4% | -132.4% |
| Capex IntensityCapex / Revenue | 0.1% | 3.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-18.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-6.1M | ||
| Q3 25 | — | $-4.3M | ||
| Q2 25 | — | $-3.1M | ||
| Q1 25 | — | $-3.8M | ||
| Q4 24 | $-1.7M | $-2.2M | ||
| Q3 24 | $-2.4M | $-1.5M | ||
| Q2 24 | $-1.4M | $-3.6M | ||
| Q1 24 | $-2.0M | $-2.8M |
| Q4 25 | — | $-6.3M | ||
| Q3 25 | — | $-4.6M | ||
| Q2 25 | — | $-3.2M | ||
| Q1 25 | — | $-4.0M | ||
| Q4 24 | $-1.7M | $-2.2M | ||
| Q3 24 | — | $-1.7M | ||
| Q2 24 | — | $-3.7M | ||
| Q1 24 | $-2.0M | $-3.0M |
| Q4 25 | — | -132.4% | ||
| Q3 25 | — | -92.1% | ||
| Q2 25 | — | -77.1% | ||
| Q1 25 | — | -180.4% | ||
| Q4 24 | -35.4% | -75.4% | ||
| Q3 24 | — | -54.5% | ||
| Q2 24 | — | -195.1% | ||
| Q1 24 | -75.3% | -586.7% |
| Q4 25 | — | 3.3% | ||
| Q3 25 | — | 7.3% | ||
| Q2 25 | — | 1.7% | ||
| Q1 25 | — | 9.0% | ||
| Q4 24 | 0.1% | 0.9% | ||
| Q3 24 | — | 5.3% | ||
| Q2 24 | 0.0% | 6.4% | ||
| Q1 24 | 0.1% | 41.5% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NBY
| Other | $2.4M | 51% |
| Total Product Revenue | $2.3M | 49% |
WKSP
Segment breakdown not available.
